| Serial Number | 88470755 |
| Word Mark | PLUS THERAPEUTICS |
| Filing Date | Wednesday, June 12, 2019 |
| Status | 807 - SU - NON-FINAL ACTION - MAILED |
| Status Date | Monday, September 2, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, November 3, 2020 |
| Description of Mark | The mark consists of the literal terms "PLUS THERAPEUTICS", with the term "PLUS" positioned over the term "THERAPEUTICS", and a "+" symbol forming a portion of the letter "P" in the literal term "PLUS". |
| Goods and Services | Nanomedicinal products for medical purposes, namely, organic and inorganic pharmaceutical preparations, nanoparticle pharmaceutical preparations, pharmaceuticals, pharmaceutical preparations and substances for the prevention and treatment of cancer, autoimmune diseases and disorders, orthopedic diseases and disorders, blood diseases and disorders, diseases and disorders of the central nervous system, oncological diseases and disorders, and ophthalmological diseases and disorders; chemical preparations for pharmaceutical and medical purposes, namely, for the prevention and treatment of cancer, autoimmune diseases and disorders, orthopedic diseases and disorders, blood diseases and disorders, diseases and disorders of the central nervous system, oncological diseases and disorders, and ophthalmological diseases and disorders; chemical reagents for medical purposes; clinical medical reagents; drug delivery agents in the form of nanoparticle powders that facilitate the delivery of pharmaceutical preparations; liposomal nanoparticle powders being drug delivery agents to facilitate delivery of genetic material and vaccines for medical purposes; all of the aforementioned for human or animal use |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Goods and Services | Medical services, namely, administration of nanomedicinal medications |
| NOT AVAILABLE | "THERAPEUTICS" |
| Goods and Services | providing medical and scientific information in the field of cancer, autoimmune diseases and disorders, orthopedic diseases and disorders, blood diseases and disorders, diseases and disorders of the central nervous system, oncological diseases and disorders, and ophthalmological diseases and disorders |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, June 25, 2019 |
| Primary Code | 005 |
| First Use Anywhere Date | Monday, December 6, 2021 |
| First Use In Commerce Date | Monday, December 6, 2021 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, June 25, 2019 |
| Primary Code | 042 |
| First Use Anywhere Date | Friday, May 6, 2022 |
| First Use In Commerce Date | Friday, May 6, 2022 |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, June 25, 2019 |
| Primary Code | 044 |
| First Use Anywhere Date | Monday, December 6, 2021 |
| First Use In Commerce Date | Monday, December 6, 2021 |
| Party Name | PLUS THERAPEUTICS, INC. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Austin, TX 78756 |
| Party Name | PLUS THERAPEUTICS, INC. |
| Party Type | 11 - New Owner Before Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Austin, TX 78756 |
| Party Name | Cytori Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | San Diego, CA 92121 |
| Event Date | Event Description |
| Saturday, June 15, 2019 | NEW APPLICATION ENTERED |
| Tuesday, June 25, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, June 26, 2019 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Wednesday, August 14, 2019 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Wednesday, September 4, 2019 | ASSIGNED TO EXAMINER |
| Thursday, September 12, 2019 | NON-FINAL ACTION WRITTEN |
| Thursday, September 12, 2019 | NON-FINAL ACTION E-MAILED |
| Thursday, September 12, 2019 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, March 9, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, March 9, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, March 10, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, April 1, 2020 | FINAL REFUSAL WRITTEN |
| Wednesday, April 1, 2020 | FINAL REFUSAL E-MAILED |
| Wednesday, April 1, 2020 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Tuesday, July 28, 2020 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Tuesday, July 28, 2020 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Tuesday, July 28, 2020 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Wednesday, September 23, 2020 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Wednesday, September 23, 2020 | EXPARTE APPEAL RECEIVED AT TTAB |
| Wednesday, September 23, 2020 | JURISDICTION RESTORED TO EXAMINING ATTORNEY |
| Wednesday, September 23, 2020 | EX PARTE APPEAL-INSTITUTED |
| Friday, September 25, 2020 | ASSIGNED TO LIE |
| Friday, September 25, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, September 25, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, September 25, 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, September 25, 2020 | EXPARTE APPEAL TERMINATED |
| Wednesday, October 14, 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, November 3, 2020 | PUBLISHED FOR OPPOSITION |
| Tuesday, November 3, 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, December 29, 2020 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Friday, June 25, 2021 | SOU TEAS EXTENSION RECEIVED |
| Friday, June 25, 2021 | SOU EXTENSION 1 FILED |
| Friday, June 25, 2021 | SOU EXTENSION 1 GRANTED |
| Tuesday, June 29, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, December 21, 2021 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, December 21, 2021 | SOU EXTENSION 2 FILED |
| Tuesday, December 21, 2021 | SOU EXTENSION 2 GRANTED |
| Thursday, December 23, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, May 18, 2022 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, May 18, 2022 | SOU EXTENSION 3 FILED |
| Wednesday, May 18, 2022 | SOU EXTENSION 3 GRANTED |
| Friday, May 20, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, October 26, 2022 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| Thursday, December 8, 2022 | SOU TEAS EXTENSION RECEIVED |
| Thursday, December 8, 2022 | SOU EXTENSION 4 FILED |
| Thursday, December 8, 2022 | SOU EXTENSION 4 GRANTED |
| Saturday, December 10, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, June 15, 2023 | SOU TEAS EXTENSION RECEIVED |
| Thursday, June 15, 2023 | SOU EXTENSION 5 FILED |
| Thursday, June 22, 2023 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Thursday, June 22, 2023 | SOU EXTENSION 5 GRANTED |
| Friday, June 23, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, December 28, 2023 | USE AMENDMENT FILED |
| Thursday, December 28, 2023 | TEAS STATEMENT OF USE RECEIVED |
| Friday, January 5, 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Wednesday, July 10, 2024 | STATEMENT OF USE PROCESSING COMPLETE |
| Monday, September 2, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, September 2, 2024 | SU - NON-FINAL ACTION - WRITTEN |
| Monday, September 2, 2024 | NON-FINAL ACTION E-MAILED |